SELLAS Life Sciences Group (SLS)
NASDAQ:SLS
Holding SLS?
Track your performance easily

SELLAS Life Sciences Group (SLS) Financial Statements

871 Followers

SELLAS Life Sciences Group Financial Overview

SELLAS Life Sciences Group's market cap is currently ―. The company's EPS TTM is $-0.923; its P/E ratio is -1.33; SELLAS Life Sciences Group is scheduled to report earnings on November 14, 2024, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -7.47M$ -9.64M$ -8.18M$ -9.36M$ -9.05M
EBITDA$ -7.33M$ -9.51M$ -8.05M$ -9.36M$ -8.89M
Net Income Common Stockholders$ -7.47M$ -9.57M$ -8.14M$ -9.27M$ -8.84M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.10M$ 18.40M$ 2.53M$ 4.00M$ 13.90M
Total Assets$ 15.12M$ 24.43M$ 6.22M$ 8.09M$ 18.56M
Total Debt$ 692.00K$ 801.00K$ 906.00K$ 644.00K$ 749.00K
Net Debt$ -8.41M$ -17.60M$ -1.62M$ -3.36M$ -13.15M
Total Liabilities$ 12.21M$ 14.75M$ 14.20M$ 11.91M$ 13.72M
Stockholders Equity$ 2.91M$ 9.68M$ -7.98M$ -3.83M$ 4.88M
Cash Flow-
Free Cash Flow$ -9.60M$ -10.80M$ -4.80M$ -6.90M$ -7.53M
Operating Cash Flow$ -9.60M$ -10.80M$ -4.80M$ -6.90M$ -7.53M
Investing Cash Flow---$ -3.00M$ -2.50M
Financing Cash Flow$ 414.00K$ 26.65M$ 3.39M$ 54.00K$ -29.00K
Currency in USD

SELLAS Life Sciences Group Earnings and Revenue History

SELLAS Life Sciences Group Debt to Assets

SELLAS Life Sciences Group Cash Flow

SELLAS Life Sciences Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis